Skip to main content
. 2018 Dec 3;17:273. doi: 10.1186/s12944-018-0923-1

Table 1.

Baseline characteristics of the study population according to Gensini score tertiles

Overall (n = 4090) Gensini score category p
< 26 26–43 ≥44
(n = 1309) (n = 1405) (n = 1376)
Clinical characteristics
 Age, years 61.1 ± 10.9 58.9 ± 10.8 61.8 ± 10.7 62.6 ± 10.8 < 0.001
 Gender (male), % (n) 67.9(2779) 62.9 (823) 68.4 (961) 72.3 (995) < 0.001
 BMI, kg/m2 25.0 ± 3.2 25.0 ± 3.3 25.0 ± 3.1 25.1 ± 3.1 0.262
 Systolic pressure, mm Hg 134 ± 20 132 ± 19 134 ± 20 135 ± 21 0.002
 Diastolic pressure, mm Hg 78 ± 12 78 ± 12 78 ± 12 78 ± 13 0.726
 Hypertension, % (n) 57.8(2362) 52.6 (689) 58.9 (827) 61.5 (846) < 0.001
 Diabetes mellitus, % (n) 23.9(977) 22.2 (290) 22.4 (315) 27.0 (372) 0.003
 Current smoking, % (n) 35.2(1438) 31.0 (406) 34.2 (480) 40.1 (552) < 0.001
 Family history of premature CAD, % (n) 145 (3.5) 45 (3.4) 60 (4.3) 40 (2.9) 0.146
 LVEF, % 61.1 ± 6.9 61.3 ± 7.0 61.0 ± 6.9 61.0 ± 6.8 0.594
Biochemistry parameters
 TC, mmol/L 4.64 ± 1.08 4.56 ± 1.02 4.61 ± 1.05 4.74 ± 1.16 < 0.001
 LDL-C, mmol/L 2.78 ± 0.91 2.68 ± 0.84 2.74 ± 0.90 2.91 ± 0.96 < 0.001
 HDL-C, mmol/L 1.14 ± 0.31 1.18 ± 0.32 1.12 ± 0.31 1.12 ± 0.30 < 0.001
 TG, mmol/L 1.51 (1.07–2.18) 1.48 (1.06–2.12) 1.46 (1.05–2.10) 1.57 (1.12–2.28) 0.003
 Hs-CRP, mg/L 2.63 (1.10–7.10) 2.47 (1.00–6.37) 2.41 (1.06–6.66) 2.99 (1.23–8.39) < 0.001
 Fasting glucose, mmol/L 6.26 ± 2.39 6.00 ± 2.11 6.27 ± 2.37 6.50 ± 2.62 < 0.001
 HbA1C, (%) 6.4 ± 1.4 6.3 ± 1.4 6.4 ± 1.4 6.6 ± 1.5 < 0.001

Data are shown as mean ± standard deviation, median (Q1–Q3 quartiles), or percentages (n). P values from analysis of the variance (ANOVA), Kruskal-Wallis H tests, or chi-square tests. Two-tailed p < 0.05 was considered statistically significant. CAD coronary artery disease, BMI body mass index, LVEF left ventricular ejection fraction, TC total cholesterol, LDL-C LDL cholesterol, HDL-C HDL cholesterol, TG triglyceride, hs-CRP high-sensitivity C reactive protein, HbA1C Hemoglobin A1c